Purchase Order 36C25925P1069
Award Date
8/21/25
Potential Completion Date
9/30/25
Potential Value
$20K
Federal Agency
Veterans Integrated Service Network 19
Awardee
Biologics, Inc.
Ultimate Awardee
Mckesson Corporation
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of the healthcare company McKesson Corporation. The $22,061.05 contract is for the delivery of cancer drugs and biologics, including medications such as TURALIO, CAPRELSA, LENALIDOMIDE, AYVAKIT, and XERMELO. The contract does not have a set-aside designation, indicating it was open to full and open competition. Biologics, Inc. has a history of...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics during fiscal year 2025. The contract has a ceiling value of $22,061.05 and an ultimate completion date of May 31, 2025. There is no set-aside designation for this contract, indicating open competition. Biologics, Inc. is a for-profit pharmaceutical company that specializes in...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Biologics, Inc., a for-profit pharmaceutical provider, for $99,184.84. The contract is for express pharmacy orders, with a period of performance ending on September 30, 2017. Biologics, Inc. has provided specialty medications such as cancer treatments to VA medical centers and Bureau of Prisons facilities in the past. This award does not have a set-aside...
This is a firm fixed-price purchase order for $91,279.43 awarded by the Veterans Integrated Service Network 22, a component of the Department of Veterans Affairs (VA), to Biologics, Inc. to provide the cancer medication Lynparza on an emergency basis. The contract period was from November 6, 2015 to September 30, 2016. This contract was not set aside for any specific business category. Biologics, Inc. is a for-profit pharmaceutical company that has provided specialty medications to various...
This is a $22,061.05 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics in fiscal year 2025. The contract has no set-aside designation, indicating open competition. Biologics, Inc. is a pharmaceutical company focused on delivering critical medical treatments, particularly cancer medications, to various federal healthcare and correctional...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA), to Mckesson Plasma And Biologics LLC, a for-profit limited liability company. The contract, valued at $145,440.00, is for the provision of pharmaceutical medications to support direct patient care for specific patients. The contract has an ultimate completion date of February 25, 2016. Mckesson Plasma And Biologics LLC, a subsidiary of...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency under the Department of Veterans Affairs (VA), to Mckesson Plasma And Biologics LLC, a for-profit limited liability company, for pharmaceutical products and medical supplies. The contract has a total ceiling value of $103,728.96 and a completion date of June 30, 2015. The contract does not have a set-aside designation. Mckesson Plasma And Biologics LLC, a subsidiary of...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Mckesson Corporation, a prime contractor that provides pharmaceuticals and medical supplies to federal government customers. The $89,846.40 contract is for the delivery of unspecified "EMERGENCY BICNU" products, with an ultimate completion date of April 8, 2017. Mckesson is a healthcare services and information technology company that has received over...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to McKesson Plasma and Biologics LLC, a subsidiary of the healthcare services company McKesson Corporation. The $3,730.60 contract is for the delivery of pharmaceutical products, including specialty drugs and biologics, to support the NIH Clinical Center's healthcare services and clinical research efforts. No set-aside designation was used for this award. McKesson...
This federal contract award, with ID VA25617P0046, was made by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Mckesson Plasma And Biologics LLC, a for-profit limited liability company that specializes in distributing pharmaceutical products and medical supplies to various government agencies. The contract, valued at $131,724.45, is for the delivery of the specialty drug Istodax on a firm fixed-price basis. This purchase order does not have a set-aside designation...